NASDAQ:MDSO - Medidata Solutions Stock Price, News & Analysis

$91.83
+0.12 (+0.13 %)
(As of 09/17/2019 04:00 PM ET)
Today's Range
$91.63
Now: $91.83
$91.86
50-Day Range
$91.22
MA: $91.50
$91.79
52-Week Range
$60.10
Now: $91.83
$98.60
Volume730,972 shs
Average Volume959,857 shs
Market Capitalization$5.74 billion
P/E Ratio95.66
Dividend YieldN/A
Beta1.23
Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development and commercialization of new therapies. The company's platform solutions include data capture and management, and trial planning and management. It also provides professional services, such as implementation, sponsor enablement, strategic consulting, partner support, and e-learning and training. Read More…

Industry, Sector and Symbol

Industry Prepackaged software
Sub-IndustryHealth Care Technology
SectorMedical
Current SymbolNASDAQ:MDSO
CUSIP58471A10
Phone212-918-1800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$635.70 million
Cash Flow$1.6924 per share
Book Value$10.32 per share

Profitability

Net Income$51.92 million

Miscellaneous

Employees1,998
Market Cap$5.74 billion
Next Earnings Date10/17/2019 (Estimated)
OptionableOptionable

Receive MDSO News and Ratings via Email

Sign-up to receive the latest news and ratings for MDSO and its competitors with MarketBeat's FREE daily newsletter.


Medidata Solutions (NASDAQ:MDSO) Frequently Asked Questions

What is Medidata Solutions' stock symbol?

Medidata Solutions trades on the NASDAQ under the ticker symbol "MDSO."

How were Medidata Solutions' earnings last quarter?

Medidata Solutions Inc (NASDAQ:MDSO) announced its earnings results on Monday, July, 22nd. The company reported $0.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.31. The business had revenue of $180.50 million for the quarter, compared to analysts' expectations of $179.95 million. Medidata Solutions had a return on equity of 8.64% and a net margin of 6.43%. The business's revenue for the quarter was up 15.8% on a year-over-year basis. During the same period last year, the firm posted $0.43 earnings per share. View Medidata Solutions' Earnings History.

When is Medidata Solutions' next earnings date?

Medidata Solutions is scheduled to release their next quarterly earnings announcement on Thursday, October 17th 2019. View Earnings Estimates for Medidata Solutions.

What price target have analysts set for MDSO?

9 Wall Street analysts have issued 1-year price targets for Medidata Solutions' shares. Their forecasts range from $70.00 to $96.00. On average, they expect Medidata Solutions' stock price to reach $84.4288 in the next year. This suggests that the stock has a possible downside of 8.1%. View Analyst Price Targets for Medidata Solutions.

What is the consensus analysts' recommendation for Medidata Solutions?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medidata Solutions in the last year. There are currently 8 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Medidata Solutions.

Has Medidata Solutions been receiving favorable news coverage?

Media stories about MDSO stock have trended negative on Tuesday, InfoTrie reports. The research group rates the sentiment of press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Medidata Solutions earned a media sentiment score of -2.9 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the next few days. View News Stories for Medidata Solutions.

Who are some of Medidata Solutions' key competitors?

What other stocks do shareholders of Medidata Solutions own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medidata Solutions investors own include NVIDIA (NVDA), Applied Materials (AMAT), salesforce.com (CRM), Gilead Sciences (GILD), Allergan (AGN), GrubHub (GRUB), IBM (IBM), Celgene (CELG), Alphabet (GOOG) and Intel (INTC).

Who are Medidata Solutions' key executives?

Medidata Solutions' management team includes the folowing people:
  • Mr. Tarek A. Sherif, Co-Founder, Chairman & CEO (Age 57)
  • Mr. Glen M. de Vries, Co-Founder, Pres & Director (Age 47)
  • Mr. Rouven Bergmann, Chief Financial Officer (Age 46)
  • Mr. Michael Pray, Exec. VP - Gen. Mang. of Global Sales (Age 53)
  • Ms. Jill Larsen, Exec. VP - HR & Chief HR Officer (Age 46)

Who are Medidata Solutions' major shareholders?

Medidata Solutions' stock is owned by many different of retail and institutional investors. Top institutional investors include BlackRock Inc. (8.98%), BlackRock Inc. (8.99%), Vanguard Group Inc. (8.75%), Brown Capital Management LLC (6.30%), Janus Henderson Group PLC (2.48%) and Janus Henderson Group PLC (2.48%). Company insiders that own Medidata Solutions stock include Carlos Dominguez, Daniel Patrick Shannon, Lee Shapiro, Michael I Otner, Michael L Capone, Michael Pray, Robert Taylor, Rouven Bergmann and Tarek Sherif. View Institutional Ownership Trends for Medidata Solutions.

Which major investors are selling Medidata Solutions stock?

MDSO stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., BlackRock Inc., ARK Investment Management LLC, Eagle Asset Management Inc., Bank of New York Mellon Corp, Global Thematic Partners LLC, Pictet Asset Management Ltd. and Peregrine Capital Management LLC. Company insiders that have sold Medidata Solutions company stock in the last year include Daniel Patrick Shannon, Michael I Otner, Michael Pray, Robert Taylor and Rouven Bergmann. View Insider Buying and Selling for Medidata Solutions.

Which major investors are buying Medidata Solutions stock?

MDSO stock was bought by a variety of institutional investors in the last quarter, including Alpine Associates Management Inc., Magnetar Financial LLC, Echo Street Capital Management LLC, ARP Americas LP, Morgan Stanley, Syquant Capital Sas, Pentwater Capital Management LP and Water Island Capital LLC. View Insider Buying and Selling for Medidata Solutions.

How do I buy shares of Medidata Solutions?

Shares of MDSO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Medidata Solutions' stock price today?

One share of MDSO stock can currently be purchased for approximately $91.83.

How big of a company is Medidata Solutions?

Medidata Solutions has a market capitalization of $5.74 billion and generates $635.70 million in revenue each year. The company earns $51.92 million in net income (profit) each year or $0.96 on an earnings per share basis. Medidata Solutions employs 1,998 workers across the globe.View Additional Information About Medidata Solutions.

What is Medidata Solutions' official website?

The official website for Medidata Solutions is http://www.mdsol.com/.

How can I contact Medidata Solutions?

Medidata Solutions' mailing address is 350 HUDSON ST. 9TH FLOOR, NEW YORK NY, 10014. The company can be reached via phone at 212-918-1800 or via email at [email protected]


MarketBeat Community Rating for Medidata Solutions (NASDAQ MDSO)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  469 (Vote Outperform)
Underperform Votes:  388 (Vote Underperform)
Total Votes:  857
MarketBeat's community ratings are surveys of what our community members think about Medidata Solutions and other stocks. Vote "Outperform" if you believe MDSO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MDSO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/17/2019 by MarketBeat.com Staff

Featured Article: Compound Interest

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel